处方兴奋剂药物:过去十年的趋势,COVID-19反应前后的趋势
Meelee L Kim1, Netrali Dalvi2, Danielle DeNufrio Valerio2
1Institute for Behavioral Health, Heller School for Social Policy and Management, Brandeis University, Waltham, MA, USA.
从2011年到2021年,兴奋剂处方从2011年到2021年增加了70%. COVID-19大流行影响了处方趋势,在不同年龄和性别的人口统计数据中,兴奋剂使用发生了显著的转变,特别是在兴奋剂素朴的患者中.
科学领域:
- 药理学和公共卫生
- 控制物质使用的流行病学
背景情况:
- COVID-19显著破坏了对阿片类药物和二胺类药物的获取.
- 关于大流行对兴奋剂药物获取和使用的影响的数据有限.
研究的目的:
- 分析发行兴奋剂药物的趋势.
- 评估COVID-19流行病响应对兴奋剂处方模式的影响.
主要方法:
- 利用了马萨诸塞州处方药监测计划 (PDMP) 2011-2021年的数据.
- 分析了根据年龄组,性别和 stimulant-naïve 患者状态的全州趋势.
主要成果:
- 在2011年至2021年期间,整体兴奋剂处方增加了70%.
- 在大流行前和后,在处方趋势中观察到基于性别和年龄的显著差异.
- 从2019年至2021年,青少年男性 (12-18岁) 的兴奋剂处方减少了,但女性增加了,并且在 stimulant-naïve 成年女性中记录了显著的增加.
结论:
- 密切监测兴奋剂处方趋势是必不可少的.
- 这种监测对于提高患者护理的准入和质量至关重要.
更多相关视频
09:16A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
相关概念视频
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Drug Therapy
Antianxiety Medications
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
